Hacker News Reader

Lots of reasons.

The new drug could be cheaper to manufacture, fewer side effects, a full cure in stead of a functional cure.

Cost of manufacture is not a meaningful driver of pricing outside the biological

How will your clinical trial of the ostensible full cure work if standard of care is curing people?

A full cure would probably have less side-effects, since a functional cure means a life-long dependence on drugs.